Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association

American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesia

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Sensitization, defined as the presence of circulating antibodies, presents challenges for heart transplant recipients and physicians. When present, sensitization can limit a transplantation candidate's access to organs, prolong wait time, and, in some cases, exclude the candidate from heart transplantation altogether. The management of sensitization is not yet standardized, and current therapies have not yielded consistent results. Although current strategies involve antibody suppression and removal with intravenous immunoglobulin, plasmapheresis, and antibody therapy, newer strategies with more specific targets are being investigated.

Original languageEnglish (US)
Pages (from-to)e553-e578
JournalCirculation
Volume139
Issue number12
DOIs
StatePublished - Mar 19 2019

Fingerprint

Intravenous Immunoglobulins
Heart Transplantation
Plasmapheresis
Antibodies
Transplantation
Physicians
Therapeutics
Transplant Recipients

Keywords

  • AHA Scientific Statements
  • antibodies
  • heart transplantation
  • human leukocyte antigen

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesia (2019). Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. Circulation, 139(12), e553-e578. https://doi.org/10.1161/CIR.0000000000000598

Sensitization in Heart Transplantation : Emerging Knowledge: A Scientific Statement From the American Heart Association. / American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesia.

In: Circulation, Vol. 139, No. 12, 19.03.2019, p. e553-e578.

Research output: Contribution to journalArticle

American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesia 2019, 'Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association', Circulation, vol. 139, no. 12, pp. e553-e578. https://doi.org/10.1161/CIR.0000000000000598
American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesia. Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. Circulation. 2019 Mar 19;139(12):e553-e578. https://doi.org/10.1161/CIR.0000000000000598
American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesia. / Sensitization in Heart Transplantation : Emerging Knowledge: A Scientific Statement From the American Heart Association. In: Circulation. 2019 ; Vol. 139, No. 12. pp. e553-e578.
@article{e152373d5a2847b38d1c3a1cc107a48a,
title = "Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association",
abstract = "Sensitization, defined as the presence of circulating antibodies, presents challenges for heart transplant recipients and physicians. When present, sensitization can limit a transplantation candidate's access to organs, prolong wait time, and, in some cases, exclude the candidate from heart transplantation altogether. The management of sensitization is not yet standardized, and current therapies have not yielded consistent results. Although current strategies involve antibody suppression and removal with intravenous immunoglobulin, plasmapheresis, and antibody therapy, newer strategies with more specific targets are being investigated.",
keywords = "AHA Scientific Statements, antibodies, heart transplantation, human leukocyte antigen",
author = "{American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesia} and Colvin, {Monica M.} and Cook, {Jennifer L.} and Chang, {Patricia P.} and Hsu, {Daphne T.} and Kiernan, {Michael S.} and Kobashigawa, {Jon A.} and Lindenfeld, {Jo Ann} and Masri, {S. Carolina} and Miller, {Dylan V.} and Rodriguez, {E. Rene} and Tyan, {Dolly B.} and Adriana Zeevi",
year = "2019",
month = "3",
day = "19",
doi = "10.1161/CIR.0000000000000598",
language = "English (US)",
volume = "139",
pages = "e553--e578",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Sensitization in Heart Transplantation

T2 - Emerging Knowledge: A Scientific Statement From the American Heart Association

AU - American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Cardiovascular Surgery and Anesthesi

AU - Colvin, Monica M.

AU - Cook, Jennifer L.

AU - Chang, Patricia P.

AU - Hsu, Daphne T.

AU - Kiernan, Michael S.

AU - Kobashigawa, Jon A.

AU - Lindenfeld, Jo Ann

AU - Masri, S. Carolina

AU - Miller, Dylan V.

AU - Rodriguez, E. Rene

AU - Tyan, Dolly B.

AU - Zeevi, Adriana

PY - 2019/3/19

Y1 - 2019/3/19

N2 - Sensitization, defined as the presence of circulating antibodies, presents challenges for heart transplant recipients and physicians. When present, sensitization can limit a transplantation candidate's access to organs, prolong wait time, and, in some cases, exclude the candidate from heart transplantation altogether. The management of sensitization is not yet standardized, and current therapies have not yielded consistent results. Although current strategies involve antibody suppression and removal with intravenous immunoglobulin, plasmapheresis, and antibody therapy, newer strategies with more specific targets are being investigated.

AB - Sensitization, defined as the presence of circulating antibodies, presents challenges for heart transplant recipients and physicians. When present, sensitization can limit a transplantation candidate's access to organs, prolong wait time, and, in some cases, exclude the candidate from heart transplantation altogether. The management of sensitization is not yet standardized, and current therapies have not yielded consistent results. Although current strategies involve antibody suppression and removal with intravenous immunoglobulin, plasmapheresis, and antibody therapy, newer strategies with more specific targets are being investigated.

KW - AHA Scientific Statements

KW - antibodies

KW - heart transplantation

KW - human leukocyte antigen

UR - http://www.scopus.com/inward/record.url?scp=85063261771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063261771&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000598

DO - 10.1161/CIR.0000000000000598

M3 - Article

C2 - 30776902

AN - SCOPUS:85063261771

VL - 139

SP - e553-e578

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 12

ER -